Efficacy of mesenchymal stem cells in the spinal cord injury of large animal models: A meta-analysis
10.3969/j.issn.2095-4344.2183
- Author:
Kong DESHENG
1
Author Information
1. Hebei Medical University-National University of Ireland Galway Stem Cell Research Center
- Publication Type:Journal Article
- Keywords:
Experiment;
Large animals;
Mesenchymal stem cells;
Meta-analysis;
Motor function;
Protein;
Spinal cord injury;
Stem cells
- From:
Chinese Journal of Tissue Engineering Research
2021;25(7):1142-1148
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: Mesenchymal stem cells transplantation is a promising treatment for spinal cord injury. Most of studies focused on small animal models. In large animal experiments, there are still controversies in selection of stem cells and therapeutic effect. This article analyzed the effects of mesenchymal stem cells orelated indicators of spinal cord injury in large animal models and evaluated their effects on spinal cord injury repair. METHODS: PubMed, Cochrane, OVID, Web of Science and CNKI databases were retrieved before December 2019. A series of studies on the treatment of spincord injury in large animal models by mesenchymal stem cells were collected. According to the inclusion criteria, two researchers independently completed literature screening, data extraction and methodological quality evaluation, and meta-analysis was conducted with Stata16.0. RESULTS: A total of 10 articles were included. The results of meta-analysis showed that: (1) Mesenchymal stem cells could significantly improve motor functioafter spinal cord injury [I2=97.73%, MD=3.94, 95%CI (2.15, 5.72), P < 0.01]. Based on cell source, observation time, intervention phase, transplantation mode and graft type subgroup analysis showed that motor scores of bone marrow mesenchymal stem cells group, non-bone marrow mesenchymal stem cells groupshort-term observation (<2 months) group, long-term observation (≥ 2 months) group, acute stage group, non-acute stage group, cells group and allograft group were significantly higher than those of control group (P < 0.01). There was no significant difference in motor score between scaffold group and control group (P > 0.05). (2) The injury size in mesenchymal stem cells treatment group was significantly smaller than that in the control group [I2=98.05%, MD=-1.00, 95%CI (-1.95,-0.04), P=0.04]. (3) There was no significant difference in the relative expression of glial fibrillary acidic protein between the mesenchymal stem cells treatment group and the control group [I2=99.48%, MD=80.61, 95%CI (-27.48, 188.70), P=0.14]. CONCLUSION: Mesenchymal stem cells transplantation has a significant improvement on the motor function and injury repair of spinal cord injury in large animals, and the security is high. Due to the limitation of the quality of the included literature, the above conclusions need to be validated by high-quality and large-sample randomized controlled trials.
